B
Barbara Fisher
Researcher at University of Western Ontario
Publications - 119
Citations - 30412
Barbara Fisher is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Radiation therapy & Temozolomide. The author has an hindex of 40, co-authored 116 publications receiving 26509 citations. Previous affiliations of Barbara Fisher include London Health Sciences Centre & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer
Gregory M.M Videtic,Barbara Fisher,Francisco Perera,Glenn Bauman,Walter Kocha,Marianne Taylor,Mark Vincent,E.A Plewes,C. Jay Engel,Larry Stitt +9 more
TL;DR: The combination of 5 FU infusion and pelvic radiation in the management of locally advanced rectal cancer is well tolerated and provides a baseline for comparison purposes with future combinations of newer systemic agents and radiation.
Journal ArticleDOI
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma
Barbara Fisher,W. Seiferheld,Christopher J. Schultz,Lisa M. DeAngelis,D. F. Nelson,S.C. Schold,Walter J. Curran,Minesh P. Mehta +7 more
TL;DR: The HFX regimen delayed but did not eliminate severe neurotoxicity from chemoradiation in PCNSL patients, and PFS and overall survival were not significantly affected.
Journal ArticleDOI
Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Barbara Fisher,Francisco Perera,A.L. Cooke,A. Opeitum,A.R. Dar,Varagur Venkatesan,Larry Stitt,J. Radwan +7 more
TL;DR: Univariate analysis of the entire 254 node-positive patient group revealed extracapsular nodal extension (ECE) to be a prognostically significant factor for actuarial and disease-free survival as well as for loco-regional failure, but ECE did not remain an independently prognostic factor after multivariate analysis.
Journal ArticleDOI
Adult supratentorial low-grade glioma: long-term experience at a single institution.
TL;DR: Function among long-term survivors without tumor progression was good to excellent for most patients and survival is possible, with selection and timing of adjuvant treatments having less influence on outcome.
Journal ArticleDOI
Ki-67: a prognostic factor for low-grade glioma?
Barbara Fisher,Elitza Naumova,Christopher Leighton,George N. Naumov,Nancy Kerklviet,David Fortin,David R. Macdonald,J. Gregory Cairncross,Glenn Bauman,Larry Stitt +9 more
TL;DR: Ki-67 was not helpful in predicting which adult patients were likely to benefit from postoperative RT, but the results of the present study indicate a possible utility in the selection of pediatric patients for RT and in theselection of poorer prognosis patients for clinical trials.